Senseonics Holdings's major customers
Ascensia accounted for 53% of Senseonics Holdings's revenue in FY 2025, down from 82% a year earlier.
Get an email when Senseonics Holdings's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Major customers of Senseonics Holdings
Customers that Senseonics Holdings named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Ascensia | 53% | ▼ from 82% | 5 years | FY 2025 · filed 2 Mar 2026 |
Formerly disclosed
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Roche Diabetes Care | 90% | last FY 2021 | 6 years | FY 2021 · filed 1 Mar 2022 |
| Edwards Healthcare Centers | 19% | last FY 2020 | 1 year | FY 2020 · filed 16 Mar 2023 |
| Advanced Diabetes Supply | 15% | last FY 2020 | 2 years | FY 2020 · filed 16 Mar 2023 |
| Solara Medical Supply | 10% | last FY 2020 | 1 year | FY 2020 · filed 16 Mar 2023 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API